← All institutions

Morgan Stanley

272 reports

Reports from this institution

Morgan Stanley

Morgan Stanley: China equities outlook for 2027 — Earnings and the currency provide marginal support; A-shares remain preferred

Morgan Stanley expects China’s economic growth to slow slightly in 2027, with exports remaining the biggest growth driver. Earnings and the renminbi provide marginal support, but earnings downgrades, weakness in property, and external uncertainty limit room for improvement. In portfolio positioning, it prefers A-shares and the domestic AI self-sufficiency chain, is overweight healthcare, and underweight internet.

Morgan Stanley

Morgan Stanley: AI and memory-price increases boost WT Microelectronics and WPG results, while cycle and financing pressures prompt rating cuts

AI server buildout and rising memory prices lifted third-quarter results at both distributors. WT issued strong fourth-quarter revenue guidance, while WPG guided to a slight sequential decline. Morgan Stanley believes data-center purchasing timing, the memory cycle, working capital and financing costs all constrain the sustainability of high growth, and cut its ratings and price targets for both companies.

Morgan Stanley

Morgan Stanley: Android smartphone shipments expected to fall 9% in 2027; earnings forecasts cut for three driver-chipmakers

Morgan Stanley lowered its global smartphone shipment forecast for 2027 from year-over-year growth of 4% to a decline of 5%. Weaker Android demand, combined with rising component costs, is squeezing driver-chip suppliers’ room to raise prices. Earnings forecasts and price targets for Egis, Himax and Goodix were all cut, though the timing and extent of the offset from new products differ.

Morgan Stanley

Morgan Stanley: Cuts Alibaba Cloud FY28 growth guidance; lowers target price to $150, maintains Overweight

Alibaba’s 2QFY27 external cloud revenue grew 64%, and cloud margins improved, but the company lowered its FY28 cloud revenue growth guidance; Morgan Stanley also cut its revenue and adjusted EBITA forecasts for the following two years. The bank remains positive on returns from T-Head and an improving cloud business mix, while e-commerce weakness and higher capital expenditure are constraints.

Morgan Stanley

Morgan Stanley: US AI controls extend to third countries and remote compute; impact to vary by region

New US Commerce Department rules extend chip export reviews to some Southeast Asian countries and require Chinese companies to obtain a license when renting large-scale computing capacity. Morgan Stanley expects Chinese cloud service providers and data centers in Southeast Asia to face greater near-term pressure on deployment and utilization, but some computing demand may shift to unaffected regions.

Morgan Stanley

Morgan Stanley: Wiwynn’s third-quarter margins beat expectations; EPS forecasts raised, but medium-term growth assumptions trimmed

Wiwynn’s third-quarter revenue rose 63% year over year, while gross and operating margins exceeded Morgan Stanley’s and market consensus estimates. The firm raised its EPS forecasts for 2026–2028, but customer revenue forecasts diverged and margins came under pressure; its model also shows substantial working-capital needs in 2027.

Morgan Stanley

Morgan Stanley: Gogo’s third-quarter equipment sales weigh on revenue; EBITDA beats expectations, but ATG metrics are soft

Equipment revenue came in below Morgan Stanley’s expectations, while services revenue and lower-than-expected operating expenses helped EBITDA beat. However, free cash flow, ATG aircraft online and shipments remained weak. The company maintained its full-year guidance, with the midpoint of its revenue and EBITDA guidance below the firm’s expectations.

Morgan Stanley

Morgan Stanley: Equity financing costs retreat as demand for leverage weakens

A dealer survey shows that the net share reporting increased demand for equity financing has fallen for two consecutive quarters from its record high in March 2026; the AXW futures-implied equity financing cost indicator has moved close to normal. Morgan Stanley says this reflects investors actively reducing leverage, and maintains its SOFR curve-flattening trade.

Morgan Stanley

Morgan Stanley: BeOne Medicines’ third-quarter revenue beats expectations; solid-tumor pipeline models raised substantially

BeOne Medicines’ third-quarter revenue grew year over year, with global Brukinsa sales reaching 1.4 billion dollars; Morgan Stanley raised its long-term sales model for the solid-tumor pipeline, but the upward revision to 2026 GAAP EPS was driven mainly by a one-time tax item, and the company’s full-year revenue guidance was slightly below the firm’s forecast.

Morgan Stanley

Morgan Stanley: The dollar may remain weak in the near term; turn bullish on DXY near EUR/USD 1.1350

Morgan Stanley believes falling energy prices and position adjustments may weigh on the dollar in the near term, but the combination of US inflation and European policy and political risks still supports dollar strength in the first quarter of 2027; the bank views a rebound in EUR/USD to 1.1350–1.14 as an entry range for shorting the euro and turning bullish on DXY.